Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 1/2 1

Status

Recruiting 747Active not recruiting 454Completed 289Not yet recruiting 199Terminated 128Enrolling by invitation 15Suspended 10Withdrawn 8Available 7No longer available 4Temporarily not available 1Approved for marketing 1

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 8

Sponsor

Cancer Type

Thoracic 8Sarcoma 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 28Neoplasms 26Prostatic Neoplasms 22Colorectal Neoplasms 17Head and Neck Neoplasms 14Pancreatic Neoplasms 11Lung Neoplasms 10Brain Neoplasms 10Neoplasm Metastasis 9Carcinoma, Renal Cell 9Squamous Cell Carcinoma of Head and Neck 8Melanoma 8Carcinoma, Non-Small-Cell Lung 8Triple Negative Breast Neoplasms 7Recurrence 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 7Lymphoma 7Glioblastoma 7Ovarian Neoplasms 6Lymphoma, Follicular 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 5Lymphoma, B-Cell 5Leukemia, Myeloid, Acute 5Leukemia 5Kidney Neoplasms 5Hematologic Neoplasms 5Sarcoma 4Liver Neoplasms 4

Interventions

vedolizumab 1pembrolizumab 1fludarabine phosphate 1fludarabine 1brigimadlin 1aldesleukin 1Methoxsalen 1Interleukin-2 1Infliximab 1Immunotherapy 1Drug Therapy 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma, Non-Small-Cell Lung × 1 year × Clear all
NCT05566223 2026-02-23

CheckCell-2

Intima Bioscience, Inc.

Phase 1/2 Withdrawn
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT05488626 2026-02-05

ARTIA-Lung

Varian, a Siemens Healthineers Company

Phase NA Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06646016 2025-12-26

EPIC

Therakos LLC

Phase 2 Withdrawn
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT00210171 2025-09-10

BIB 01

Institut Bergonié

Phase 2 Withdrawn
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT06084689 2025-09-02

EMPIRE

Institut Bergonié

Phase 2 Withdrawn
BreastGastrointestinalSarcomaThoracic

Tertiary Lymphoid Structures, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Sarcoma, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT06555263 2025-08-22

Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer

Sutro Biopharma, Inc.

Phase 2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06676917 2025-08-08

TUXEDO-5

MedSIR

Phase 2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT04615884 2025-07-28

CH:II

Lady Davis Institute

Phase NA Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡